• Joint Corp JYNT.OQ reported a quarterly adjusted loss of 18 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -75 cents. The mean expectation of five analysts for the quarter was for earnings of one cent per share. Wall Street expected results to range from -8 cents to 7 cents per share.

• Revenue fell 52.8% to $14.45 million from a year ago; analysts expected $28.99 million.

• Joint Corp's reported EPS for the quarter was a loss of 18 cents​.

• The company reported a quarterly loss of $2.72 million.

• Joint Corp shares had fallen by 1.0% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

Wall Street's median 12-month price target for Joint Corp is $17.50

This summary was machine generated from LSEG data March 13 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)